Maria Leandro, MD,PhD,FRCP

UCL/UCLH
London, United Kingdom

Adult and Adolescent Rheumatologist with expertise on B cell targeting therapies in autoimmune diseases and B cell roles in the pathogenesis of autoimmune rheumatic diseases

Presentation(s):

• 2458: Obecabtagene autoleucel (obe-cel), a CD19-targeting Autologous Chimeric Antigen Receptor T-cell Therapy (CAR T) with a fast off-rate binding domain, in Patients (pts) with Severe, Refractory Systemic Lupus Erythematosus (srSLE): Preliminary Results from the Phase I CARLYSLE Study

  Tuesday, October 28, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): Autolus: Autolus will be covering costs of me attending ACR Convergence 2025 for me to present the poster (Ongoing); GlaxoSmithKlein(GSK): Advisor or Review Panel Member (Ongoing), Consultant (Ongoing); Roche Basel: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing); UCB: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing)